Investment Analysis Portfolio
Comprehensive business analyses following Charlie Munger’s investment framework. Each analysis includes business model evaluation, competitive positioning, financial assessment, risk analysis, and valuation.
Analysis Framework
Every analysis follows this systematic approach:
- Circle of Competence Check - Can we understand this business?
- Business Model Analysis - How does it make money?
- Competitive Moat Assessment - What protects profits?
- Financial Health Review - Balance sheet and cash flows
- Management Evaluation - Capital allocation and integrity
- Risk Analysis - What could go wrong?
- Valuation Assessment - Price vs intrinsic value
- Investment Decision - Buy/sell/hold with conviction level
Analysis Portfolio
Technology & Software
Alibaba - Chinese E-commerce Platform
Strong business fundamentals but significant regulatory and competitive risks
Figma - Design Software Platform
Dominant market position but extreme valuation at 32.6x EV/Revenue
Rocket Lab - Aerospace & Launch
#2 U.S. space launch provider with strong positioning but high valuation
Consumer & Retail
Costco - Warehouse Club Retail
Exceptional business model with membership moats, but 54x P/E lacks margin of safety
Lululemon - Athletic Apparel
Temporary headwinds creating opportunity for quality brand with 40-70% upside potential
Consumer Staples & Transportation
Coca-Cola - Global Beverages
Classic Munger investment with durable moats, predictable cash flows, and reasonable valuation
Uber - Platform Mobility
Successful transformation to profitability but limited margin of safety at current valuation
Healthcare & Pharmaceuticals
Eli Lilly - Diabetes & Obesity Pharmaceuticals
Exceptional GLP-1 franchise with dominant market position but trading at 47-61% premium to fair value
Novo Nordisk - Diabetes & Obesity Care
Dominant GLP-1 franchise trading at 35-52% discount to intrinsic value following competitive concerns
Bangkok Dusit Medical - Thai Healthcare
Leading Southeast Asian healthcare provider with attractive valuation despite regional risks
Analysis Statistics
By Recommendation
- Buy: 3 (33%)
- Hold: 6 (67%)
- Sell: 0 (0%)
By Sector
- Technology: 3 analyses
- Consumer Discretionary: 2 analyses
- Consumer Staples: 1 analysis
- Transportation: 1 analysis
- Healthcare: 3 analyses
Key Insights
- Most quality businesses currently trade at full/high valuations
- Limited opportunities with adequate margin of safety
- Patience required for better entry points
- Focus on business quality over current price action
Analysis Quality Metrics
Research Standards:
- ✅ Primary source verification (10-K, earnings calls)
- ✅ Disconfirming evidence actively sought
- ✅ Multiple valuation scenarios analyzed
- ✅ Margin of safety calculations
- ✅ Opportunity cost assessments
Average Analysis Time: 12-18 hours per company
Follow-up Cadence: Quarterly earnings review, annual deep dive
All analyses follow the same rigorous framework to ensure consistency and quality. Recommendations reflect margin of safety principles rather than short-term price movements.